BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome. Annu Rev Med. 2001;52:319-338. [PMID: 11160782 DOI: 10.1146/annurev.med.52.1.319] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Seres G, Kovács Z, Kovács Á, Kerékgyártó O, Sárdi K, Demeter P, Mészáros E, Túry F. Different Associations of Health Related Quality of Life with Pain, Psychological Distress and Coping Strategies in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disorder. J Clin Psychol Med Settings 2008;15:287-95. [DOI: 10.1007/s10880-008-9132-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
2 Borji R, Fereshtehnejad SM, Taba Taba Vakili S, Daryani NE, Ajdarkosh H. Association between irritable bowel syndrome and restless legs syndrome: a comparative study with control group. J Neurogastroenterol Motil 2012;18:426-33. [PMID: 23106004 DOI: 10.5056/jnm.2012.18.4.426] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Myers DL, Aguilar VC. Gynecologic Manifestations of Interstitial Cystitis: . Clinical Obstetrics and Gynecology 2002;45:233-41. [DOI: 10.1097/00003081-200203000-00024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
4 Martin M, Chapman SC. Cognitive processing in putative functional gastrointestinal disorder: rumination yields orientation to social threat not pain. Eur J Pain. 2010;14:207-213. [PMID: 19473856 DOI: 10.1016/j.ejpain.2009.04.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
5 Lydiard RB. Increased prevalence of functional gastrointestinal disorders in panic disorder: clinical and theoretical implications. CNS Spectr 2005;10:899-908. [PMID: 16273019 DOI: 10.1017/s1092852900019878] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
6 Afsar B, Elsurer R, Yilmaz MI, Eyileten T, Yenicesu M. Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression. Nephrology 2010;15:197-202. [DOI: 10.1111/j.1440-1797.2009.01189.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Wood JD. Neuropathophysiology of the Irritable Bowel Syndrome. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 1643-68. [DOI: 10.1016/b978-0-12-809954-4.00067-0] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Carroll IM, Chang YH, Park J, Sartor RB, Ringel Y. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog. 2010;2:19. [PMID: 21143915 DOI: 10.1186/1757-4749-2-19] [Cited by in Crossref: 115] [Cited by in F6Publishing: 113] [Article Influence: 9.6] [Reference Citation Analysis]
9 Getto L, Zeserson E, Breyer M. Vomiting, diarrhea, constipation, and gastroenteritis. Emerg Med Clin North Am 2011;29:211-37, vii-viii. [PMID: 21515177 DOI: 10.1016/j.emc.2011.01.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wood JD. Neuropathophysiology of functional gastrointestinal disorders. World J Gastroenterol 2007; 13(9): 1313-1332 [PMID: 17457962 DOI: 10.3748/wjg.v13.i9.1313] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
11 Song GH, Venkatraman V, Ho KY, Chee MW, Yeoh KG, Wilder-Smith CH. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain. 2006;126:79-90. [PMID: 16846694 DOI: 10.1016/j.pain.2006.06.017] [Cited by in Crossref: 135] [Cited by in F6Publishing: 131] [Article Influence: 8.4] [Reference Citation Analysis]
12 Rao S, Weber HC. New treatment targets for the management of irritable bowel syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 2014;21:9-14. [DOI: 10.1097/med.0000000000000034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
13 Wollny T, Daniluk T, Piktel E, Wnorowska U, Bukłaha A, Głuszek K, Durnaś B, Bucki R. Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome. Pathogens 2021;10:1545. [PMID: 34959500 DOI: 10.3390/pathogens10121545] [Reference Citation Analysis]
14 Yale SH, Musana AK, Kieke A, Hayes J, Glurich I, Chyou PH. Applying case definition criteria to irritable bowel syndrome. Clin Med Res 2008;6:9-16. [PMID: 18591372 DOI: 10.3121/cmr.2008.788] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
15 El-Metwally A, Halder S, Thompson D, Macfarlane GJ, Jones GT. Predictors of abdominal pain in schoolchildren: a 4-year population-based prospective study. Arch Dis Child 2007;92:1094-8. [PMID: 17804590 DOI: 10.1136/adc.2006.115089] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
16 Ringel Y. New directions in brain imaging research in functional gastrointestinal disorders. Dig Dis. 2006;24:278-285. [PMID: 16849855 DOI: 10.1159/000092881] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
17 Savas LS, White DL, Wieman M, Daci K, Fitzgerald S, Laday Smith S, Tan G, Graham DP, Cully JA, El-Serag HB. Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther. 2009;29:115-125. [PMID: 18785989 DOI: 10.1111/j.1365-2036.2008.03847.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
18 Hod K, Dickman R, Sperber A, Melamed S, Dekel R, Ron Y, Halpern Z, Berliner S, Maharshak N. Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome: Hs-CRP in irritable bowel syndrome. Neurogastroenterology & Motility 2011;23:1105-10. [DOI: 10.1111/j.1365-2982.2011.01788.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
19 De Giorgio R, Barbara G, Stanghellini V, Cremon C, Salvioli B, De Ponti F, Corinaldesi R. Diagnosis and therapy of irritable bowel syndrome: CLINICAL FEATURES AND TREATMENT OF IBS. Alimentary Pharmacology & Therapeutics 2004;20:10-22. [DOI: 10.1111/j.1365-2036.2004.02038.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
20 Dai Y, Liu JX, Li JX, Xu YF. Effect of pinaverium bromide on stress-induced colonic smooth muscle contractility disorder in rats. World J Gastroenterol 2003; 9(3): 557-561 [PMID: 12632518 DOI: 10.3748/wjg.v9.i3.557] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
21 Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. The Lancet 2020;396:1675-88. [DOI: 10.1016/s0140-6736(20)31548-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 11] [Article Influence: 21.0] [Reference Citation Analysis]
22 Sperber AD, Shvartzman P, Friger M, Fich A. Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil 2005;17:207-11. [PMID: 15787941 DOI: 10.1111/j.1365-2982.2005.00623.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
23 Larauche M, Bradesi S, Million M, McLean P, Taché Y, Mayer EA, McRoberts JA. Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1033-G1040. [PMID: 18308857 DOI: 10.1152/ajpgi.00507.2007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 4.0] [Reference Citation Analysis]
24 Crentsil V. Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome? Med Hypotheses 2005;65:97-102. [PMID: 15893125 DOI: 10.1016/j.mehy.2004.07.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
25 Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004;97:1166-1177. [PMID: 15546407 DOI: 10.1111/j.1365-2672.2004.02409.x] [Cited by in Crossref: 683] [Cited by in F6Publishing: 652] [Article Influence: 40.2] [Reference Citation Analysis]
26 Lee YY, Waid A, Tan HJ, Chua SB, Whitehead WE. Validity and reliability of the Malay-language translation of the Rome III Diagnostic Questionnaire for irritable bowel syndrome. J Gastroenterol Hepatol. 2012;27:746-750. [PMID: 22004172 DOI: 10.1111/j.1440-1746.2011.06943.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
27 Rao SG, Bennett RM. Pharmacological therapies in fibromyalgia. Best Practice & Research Clinical Rheumatology 2003;17:611-27. [DOI: 10.1016/s1521-6942(03)00030-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
28 Chapman S, Martin M. Attention to pain words in irritable bowel syndrome: increased orienting and speeded engagement. Br J Health Psychol. 2011;16:47-60. [PMID: 21226783 DOI: 10.1348/135910710x505887] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
29 Ringel Y. Brain research in functional gastrointestinal disorders. J Clin Gastroenterol. 2002;35:S23-S25. [PMID: 12184135 DOI: 10.1097/00004836-200207001-00005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
30 Hod K, Ringel-Kulka T, Martin CF, Maharshak N, Ringel Y. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. J Clin Gastroenterol. 2016;50:227-232. [PMID: 25930973 DOI: 10.1097/mcg.0000000000000327] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
31 Chalaye P, Goffaux P, Bourgault P, Lafrenaye S, Devroede G, Watier A, Marchand S. Comparing Pain Modulation and Autonomic Responses in Fibromyalgia and Irritable Bowel Syndrome Patients. The Clinical Journal of Pain 2012;28:519-26. [DOI: 10.1097/ajp.0b013e31823ae69e] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
32 Zhu X, Chen W, Zhu X, Shen Y. A cross-sectional study of risk factors for irritable bowel syndrome in children 8-13 years of age in suzhou, china. Gastroenterol Res Pract. 2014;2014:198461. [PMID: 24899889 DOI: 10.1155/2014/198461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
33 Han B. Correlation between gastrointestinal hormones and anxiety-depressive states in irritable bowel syndrome. Exp Ther Med. 2013;6:715-720. [PMID: 24137253 DOI: 10.3892/etm.2013.1211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
34 Chen DP, Xiong YJ, Tang ZY, Yao QY, Ye DM, Liu SS, Lin Y. Characteristics of deslanoside-induced modulation on jejunal contractility. World J Gastroenterol 2012; 18(41): 5889-5896 [PMID: 23139604 DOI: 10.3748/wjg.v18.i41.5889] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
35 Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol. 2004;99:1572-1578. [PMID: 15307879 DOI: 10.1111/j.1572-0241.2004.40188.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
36 Bradley LA, Mckendree-smith NL, Cianfrini LR. Cognitive-behavioral therapy interventions for pain associated with chronic illnesses. Seminars in Pain Medicine 2003;1:44-54. [DOI: 10.1016/s1537-5897(03)00026-0] [Cited by in Crossref: 15] [Article Influence: 0.8] [Reference Citation Analysis]
37 Xie DP, Li W, Qu SY, Zheng TZ, Yang YL, Ding YH, Wei YL, Chen LB. Effect of areca on contraction of colonic muscle strips in rats. World J Gastroenterol 2002; 8(2): 350-352 [PMID: 11925623 DOI: 10.3748/wjg.v8.i2.350] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
38 Martino A, Cammarota G, Cianci R, Bianchi A, Sacco E, Tilaro L, Marzetti E, Certo M, Pirozzi G, Fedeli P. High prevalence of hyperplastic colonic polyps in acromegalic subjects. Dig Dis Sci. 2004;49:662-666. [PMID: 15185875 DOI: 10.1023/b:ddas.0000026315.91800.b2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
39 Cash BD, Rubenstein JH, Young PE, Gentry A, Nojkov B, Lee D, Andrews AH, Dobhan R, Chey WD. The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology. 2011;141:1187-1193. [PMID: 21762658 DOI: 10.1053/j.gastro.2011.06.084] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
40 Henderson WA, Thomas DA, Cantor FK, Hunter CM. News from NIH: pain management. Transl Behav Med 2012;2:1-2. [PMID: 24073090 DOI: 10.1007/s13142-012-0116-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Ringel Y, Whitehead WE, Toner BB, Diamant NE, Hu Y, Jia H, Bangdiwala SI, Drossman DA. Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome. Gut 2004;53:838-42. [PMID: 15138210 DOI: 10.1136/gut.2003.021725] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
42 Louis E, DeLooze D, Deprez P, Hiele M, Urbain D, Pelckmans P, Devière J, Deltenre M. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol. 2002;14:279-284. [PMID: 11953693 DOI: 10.1097/00042737-200203000-00012] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 3.8] [Reference Citation Analysis]
43 Carroll IM, Threadgill DW, Threadgill DS. The gastrointestinal microbiome: a malleable, third genome of mammals. Mamm Genome 2009;20:395-403. [PMID: 19629594 DOI: 10.1007/s00335-009-9204-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
44 Tsang SW, Zhao M, Wu J, Sung JJ, Bian ZX. Nerve growth factor-mediated neuronal plasticity in spinal cord contributes to neonatal maternal separation-induced visceral hypersensitivity in rats. Eur J Pain. 2012;16:463-472. [PMID: 22396076 DOI: 10.1016/j.ejpain.2011.07.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
45 Wood JD. Pathophysiology Underlying the Irritable Bowel Syndrome. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 1009-31. [DOI: 10.1016/b978-012088394-3/50044-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
46 Ismail IM, Andrew PD, Cholerton J, Roberts AD, Dear GJ, Taylor S, Koch KM, Saynor DA. Characterization of the metabolites of alosetron in experimental animals and human. Xenobiotica. 2005;35:131-154. [PMID: 16019944 DOI: 10.1080/00498250400028247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
47 Heitkemper MM, Cain KC, Jarrett ME, Burr RL, Hertig V, Bond EF. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterology 2003;98:420-30. [DOI: 10.1111/j.1572-0241.2003.07233.x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 99] [Article Influence: 6.2] [Reference Citation Analysis]
48 Angriman M, Cortese S, Bruni O. Somatic and neuropsychiatric comorbidities in pediatric restless legs syndrome: A systematic review of the literature. Sleep Medicine Reviews 2017;34:34-45. [DOI: 10.1016/j.smrv.2016.06.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
49 Coss-Adame E, Rao SS. Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings. Curr Gastroenterol Rep. 2014;16:379. [PMID: 24595616 DOI: 10.1007/s11894-014-0379-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
50 Wood JD. Pathophysiology Underlying the Irritable Bowel Syndrome. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 2157-81. [DOI: 10.1016/b978-0-12-382026-6.00081-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
51 Busby RW, Bryant AP, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Mahajan-Miklos S, Pierce CM, Solinga RM, Sun LJ. Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. Eur J Pharmacol. 2010;649:328-335. [PMID: 20863829 DOI: 10.1016/j.ejphar.2010.09.019] [Cited by in Crossref: 145] [Cited by in F6Publishing: 132] [Article Influence: 12.1] [Reference Citation Analysis]
52 Clouse RE, Lustman PJ. Use of psychopharmacological agents for functional gastrointestinal disorders. Gut. 2005;54:1332-1341. [PMID: 16099800 DOI: 10.1136/gut.2004.048884] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
53 Basu PP, Shah NJ, Krishnaswamy N, Pacana T. Prevalence of restless legs syndrome in patients with irritable bowel syndrome. World J Gastroenterol 2011; 17(39): 4404-4407 [PMID: 22110266 DOI: 10.3748/wjg.v17.i39.4404] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
54 Cohen H, Jotkowitz A, Buskila D, Pelles-avraham S, Kaplan Z, Neumann L, Sperber AD. Post-traumatic stress disorder and other co-morbidities in a sample population of patients with irritable bowel syndrome. European Journal of Internal Medicine 2006;17:567-71. [DOI: 10.1016/j.ejim.2006.07.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
55 Petrella C, Giuli C, Agostini S, Bacquie V, Zinni M, Theodorou V, Broccardo M, Casolini P, Improta G. Maternal exposure to low levels of corticosterone during lactation protects against experimental inflammatory colitis-induced damage in adult rat offspring. PLoS One 2014;9:e113389. [PMID: 25405993 DOI: 10.1371/journal.pone.0113389] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
56 Sperber AD, Shvartzman P, Friger M, Fich A. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the ‘true’ prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol. 2007;19:441-447. [PMID: 17489053 DOI: 10.1097/meg.0b013e32801140e2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
57 Yacob D, Di Lorenzo C, Bridge JA, Rosenstein PF, Onorato M, Bravender T, Campo JV. Prevalence of Pain-Predominant Functional Gastrointestinal Disorders and Somatic Symptoms in Patients with Anxiety or Depressive Disorders. The Journal of Pediatrics 2013;163:767-70. [DOI: 10.1016/j.jpeds.2013.02.033] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
58 Ma XP, Tan LY, Yang Y, Wu HG, Jiang B, Liu HR, Yang L. Effect of electro-acupuncture on substance P, its receptor and corticotropin-releasing hormone in rats with irritable bowel syndrome. World J Gastroenterol 2009; 15(41): 5211-5217 [PMID: 19891022 DOI: 10.3748/wjg.15.5211] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
59 Wood JD, Liu S, Drossman DA, Ringel Y, Whitehead WE. Anti-enteric neuronal antibodies and the irritable bowel syndrome. J Neurogastroenterol Motil. 2012;18:78-85. [PMID: 22323991 DOI: 10.5056/jnm.2012.18.1.78] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
60 Harris M, Aziz Q. Brain-gut interaction in irritable bowel syndrome. Hospital Medicine 2003;64:264-9. [DOI: 10.12968/hosp.2003.64.5.1757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
61 Lam JY, Kidane B, Manji F, Taylor BM. Improved health-related quality of life after surgical management of severe refractory constipation-dominant irritable bowel syndrome. Int Surg 2015;100:63-9. [PMID: 25594641 DOI: 10.9738/INTSURG-D-13-00212.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
62 Brown BT, Bonello R, Pollard H. The biopsychosocial model and hypothyroidism. Chiropr Osteopat 2005;13:5. [PMID: 15967049 DOI: 10.1186/1746-1340-13-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
63 Heitkemper M, Jarrett M, Bond EF, Chang L. Impact of Sex and Gender on Irritable Bowel Syndrome. Biological Research For Nursing 2003;5:56-65. [DOI: 10.1177/1099800403005001006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 10.7] [Reference Citation Analysis]
64 Mayer EA, Tillisch K, Bradesi S. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther. 2006;24:919-933. [PMID: 16948804 DOI: 10.1111/j.1365-2036.2006.03078.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
65 Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis. 2007;39:530-536. [PMID: 17420159 DOI: 10.1016/j.dld.2007.02.006] [Cited by in Crossref: 118] [Cited by in F6Publishing: 91] [Article Influence: 7.9] [Reference Citation Analysis]
66 Hillilä MT, Hämäläinen J, Heikkinen ME, Färkkilä MA. Gastrointestinal complaints among subjects with depressive symptoms in the general population. Aliment Pharmacol Ther 2008;28:648-54. [PMID: 18564324 DOI: 10.1111/j.1365-2036.2008.03771.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
67 Zeng F, Liu XG, Li XZ, Liang FR. Research progress in brain function imaging of irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2008; 16(13): 1435-1439 [DOI: 10.11569/wcjd.v16.i13.1435] [Reference Citation Analysis]
68 彭颖, 李晓波. 倍半萜内酯类治疗肠易激综合征的应用前景. 世界华人消化杂志 2017; 25(18): 1624-1632 [DOI: 10.11569/wcjd.v25.i18.1624] [Reference Citation Analysis]
69 Ringel Y, Drossman DA. Irritable bowel syndrome: classification and conceptualization. J Clin Gastroenterol. 2002;35:S7-S10. [PMID: 12184143 DOI: 10.1097/00004836-200207001-00003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
70 Sperber AD, Friger M, Shvartzman P, Abu-Rabia M, Abu-Rabia R, Abu-Rashid M, Albedour K, Alkranawi O, Eisenberg A, Kazanoviz A. Rates of functional bowel disorders among Israeli Bedouins in rural areas compared with those who moved to permanent towns. Clin Gastroenterol Hepatol. 2005;3:342-348. [PMID: 15822039 DOI: 10.1016/s1542-3565(04)00553-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
71 Collins SM. A case for an immunological basis for irritable bowel syndrome. Gastroenterology. 2002;122:2078-2080. [PMID: 12055614 DOI: 10.1053/gast.2002.34097] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
72 Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. The Lancet 2020;396:1664-74. [DOI: 10.1016/s0140-6736(20)32115-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 9.5] [Reference Citation Analysis]
73 Bevan JL. Interpersonal communication apprehension, topic avoidance, and the experience of irritable bowel syndrome. Personal Relationships 2009;16:147-65. [DOI: 10.1111/j.1475-6811.2009.01216.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
74 Ruigómez A, García Rodríguez LA, Johansson S, Wallander MA. Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome. Maturitas. 2003;44:133-140. [PMID: 12590009 DOI: 10.1016/S0378-5122(02)00321-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
75 Nakamura RM, Matsutani M, Barry M. Advances in clinical laboratory tests for inflammatory bowel disease. Clin Chim Acta. 2003;335:9-20. [PMID: 12927679 DOI: 10.1016/s0009-8981(03)00286-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
76 Wood JD. Enteric Nervous System: Neuropathic Gastrointestinal Motility. Dig Dis Sci 2016;61:1803-16. [DOI: 10.1007/s10620-016-4183-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
77 Hong Y, Liang WM. Effect of heroin dependence on expression of 5-hydroxytryptamine and somatostatin in endocrine cells of rat colon. Shijie Huaren Xiaohua Zazhi 2009; 17(10): 976-980 [DOI: 10.11569/wcjd.v17.i10.976] [Cited by in F6Publishing: 1] [Reference Citation Analysis]